United Therapeutics Corporation (UTHR)

United Therapeutics Revenue

United Therapeutics had revenue of $832.50M in the quarter ending September 30, 2026, with 4.13% growth. This brings the company's total for the last twelve months to $3.19B, up 1.89% year-over-year. In the year 2025, United Therapeutics had annual revenue of $3.18B with 10.61% growth. That makes United Therapeutics the 3,664th largest company in the world by revenue and 1,015th in the United States.

• Revenue (ttm): $3.19B
• Revenue Growth: +1.89%
• P/S Ratio: 8.19
• Revenue / Employee: $2,276,786
• Employees: 1,400
• Market Cap: 26.10B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Tyvaso 1.88B 59.0%
• Remodulin 526.80M 16.6%
• Orenitram 496.90M 15.6%
• Unituxin 226.80M 7.1%
• Adcirca 30.00M 0.9%
• Other 24.00M 0.8%

By Geography

Chart

• United States 3.04B 95.4%
• Rest-of-World 145.70M 4.6%

Fiscal year ended Dec 31, 2025 See the full United Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.18B	305.30M	10.61%
Dec 31, 2024	2.88B	549.90M	23.63%
Dec 31, 2023	2.33B	391.20M	20.20%
Dec 31, 2022	1.94B	250.80M	14.88%
Dec 31, 2021	1.69B	202.20M	13.63%
Dec 31, 2020	1.48B	34.50M	2.38%
Dec 31, 2019	1.45B	-179.00M	-11.00%
Dec 31, 2018	1.63B	-97.50M	-5.65%
Dec 31, 2017	1.73B	126.50M	7.91%
Dec 31, 2016	1.60B	133.00M	9.07%
Dec 31, 2015	1.47B	177.30M	13.76%
Dec 31, 2014	1.29B	171.52M	15.36%
Dec 31, 2013	1.12B	200.91M	21.93%
Dec 31, 2012	916.08M	172.89M	23.26%
Dec 31, 2011	743.18M	150.28M	25.35%
Dec 31, 2010	592.90M	234.02M	65.21%
Dec 31, 2009	358.88M	77.38M	27.49%
Dec 31, 2008	281.50M	70.55M	33.45%
Dec 31, 2007	210.94M	51.31M	32.14%
Dec 31, 2006	159.63M	43.72M	37.71%
Dec 31, 2005	115.92M	-	-

Data Source: Fiscal.ai Last updated: Nov 4, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error